2024-10-21 19:47:07
New Therapy to Treat Advanced Small Cell Lung Cancer ZEPZELCA® (lurbinectedin) Approved in Singapore
Health/ 2023-07-22
New Therapy to Treat Advanced Small Cell...

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC...

Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA
Corporate/ 2023-07-23
Samsung Biologics showcases its newest C...

INCHEON,South Korea,Sept. 22,2021-- Samsung Biologics,a global contract development and manufacturing organization (CDMO),introduced its pro...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release